These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfecta. Beuzeboc P; Pierga JY; Stoppa-Lyonnet D; Etienne MC; Milano G; Pouillart P Eur J Cancer; 1996 Feb; 32A(2):369-70. PubMed ID: 8664058 [No Abstract] [Full Text] [Related]
28. A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency. Vreken P; Van Kuilenburg AB; Meinsma R; Smit GP; Bakker HD; De Abreu RA; van Gennip AH J Inherit Metab Dis; 1996; 19(5):645-54. PubMed ID: 8892022 [TBL] [Abstract][Full Text] [Related]
29. Human polymorphism in drug metabolism: mutation in the dihydropyrimidine dehydrogenase gene results in exon skipping and thymine uracilurea. Meinsma R; Fernandez-Salguero P; Van Kuilenburg AB; Van Gennip AH; Gonzalez FJ DNA Cell Biol; 1995 Jan; 14(1):1-6. PubMed ID: 7832988 [TBL] [Abstract][Full Text] [Related]
30. Dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil associated toxicity. van Kuilenburg AB; Haasjes J; Van Lenthe H; Zoetekouw L; Waterham HR; Vreken P; van Gennip AH Adv Exp Med Biol; 2000; 486():251-5. PubMed ID: 11783494 [No Abstract] [Full Text] [Related]
31. Thirteen years experience with selective screening for disorders in purine and pyrimidine metabolism. Castro M; Carrillo R; García F; Sanz P; Ferrer I; Ruiz-Sala P; Vega AI; Ruíz Desviat L; Pérez B; Pérez-Cerdá C; Merinero B; Ugarte M Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):233-40. PubMed ID: 24940674 [TBL] [Abstract][Full Text] [Related]
32. [Dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity]. Foa C; Bondiau PY; Largillier R; Milano G; Magné N Rev Med Interne; 2000 Dec; 21(12):1134-5. PubMed ID: 11191685 [No Abstract] [Full Text] [Related]
33. [A case of gastric cancer with decreased dihydropyrimidine dehydrogenase activity]. Kobayashi K; Sumi S; Kidouchi K; Mizuno I; Mohri N; Fukui T; Akamo Y; Takeyama H; Manabe T Gan To Kagaku Ryoho; 1998 Jul; 25(8):1217-9. PubMed ID: 9679586 [TBL] [Abstract][Full Text] [Related]
34. Dihydrothymine dehydrogenase deficiency in a family, leading to elevated levels of uracil and thymine. De Abreu RA; Bakkeren JA; Braakhekke J; Gabreels FJ; Maas JM; Sengers RC Adv Exp Med Biol; 1986; 195 Pt A():77-80. PubMed ID: 3728188 [No Abstract] [Full Text] [Related]
36. Severe 5-fluorouracil toxicity in a patient with decreased dihydropyrimidine dehydrogenase activity. Lyss AP; Lilenbaum RC; Harris BE; Diasio RB Cancer Invest; 1993; 11(2):239-40. PubMed ID: 8462026 [No Abstract] [Full Text] [Related]
37. A pivotal role for beta-aminoisobutyric acid and oxidative stress in dihydropyrimidine dehydrogenase deficiency? van Kuilenburg AB; Stroomer AE; Abeling NG; van Gennip AH Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1103-6. PubMed ID: 17065072 [TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of the human dihydropyrimidine dehydrogenase gene by denaturing high-performance liquid chromatography. Fischer J; Schwab M; Eichelbaum M; Zanger UM Genet Test; 2003; 7(2):97-105. PubMed ID: 12885330 [TBL] [Abstract][Full Text] [Related]
39. Capillary electrophoresis for detection of inherited disorders of purine and pyrimidine metabolism. Adam T; Friedecký D; Fairbanks LD; Sevcík J; Barták P Clin Chem; 1999 Dec; 45(12):2086-93. PubMed ID: 10585670 [TBL] [Abstract][Full Text] [Related]
40. Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity. Wei X; McLeod HL; McMurrough J; Gonzalez FJ; Fernandez-Salguero P J Clin Invest; 1996 Aug; 98(3):610-5. PubMed ID: 8698850 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]